The FDA has not displayed sufficient urgency throughout the COVID-19 crisis—and is threatening to repeat its mistakes with the ongoing outbreak of monkeypox. It’s long past time for lawmakers to reform the sclerotic agency.
These “negotiations” are just price controls in disguise. As such, they’d decimate medical innovation and deprive patients of access to lifesaving medications.
The sheer number of regulatory and administrative requirements placed on doctors and other healthcare workers has made these professions far more stressful, tedious, and exhausting than they need to be.
Patients and providers should lament the increasing corporatization of medicine. All too often, it’s a recipe for lower-quality, higher-priced health care.
Americans living in non-expansion states should consider themselves lucky. Expanding Medicaid would only expand the entitlement’s inefficiencies and poor health outcomes.
Permanently rolling back restrictive scope-of-practice laws—and letting experienced healthcare workers do their jobs—is a common-sense reform that could benefit patients and the healthcare system alike.